Gilead Sciences
American biopharmaceutical company
Ownership
Gilead Sciences has no majority owner. Its largest known holders are all institutional investors:
Index funds and asset managers hold stakes in most listed companies, so these are listed separately from strategic owners.
- BlackRock, Inc. 9.1%
- BlackRock 9.0%
- The Vanguard Group 9.0%
- Vanguard Capital Management 7.1%
- Fmr LLC 5.5%
- State Street Corporation 4.6%
- Capital World Investors 3.2%
- Vanguard Portfolio Management 2.7%
- JPMorgan Chase 2.6%
- Geode Capital Management 2.3%
These holders account for 76% of Gilead Sciences. The remainder is free float or not yet recorded.
What Gilead Sciences owns
Part-owned
Share not stated
Recorded as owned, but no source gives the size of the stake — it may be all of the company or a small part of it.
Similar companies
In Pharmaceuticals, under different ownership.
Websites
- gilead.com
Sources
- Gilead Sciences, Inc. — SEC EDGAR
- SCHEDULE 13G — Vanguard Capital Management — SEC EDGAR
- SCHEDULE 13G — FMR LLC — SEC EDGAR
- SCHEDULE 13G/A — Capital World Investors — SEC EDGAR
- SCHEDULE 13G/A — BlackRock, Inc. — SEC EDGAR
- Gilead Sciences — Wikidata